RECRUITING

Personalized Mobile Cognitive Behavioral Therapy Application

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to compare the effectiveness of a standard mobile iPhone cognitive behavioral therapy program to a personalized mobile iPhone cognitive behavioral therapy program that introduces new skills over a shorter period of time. Participants will use the Maya app for two days per week, at least 20 minutes per day, for six weeks. Assessments will include a weekly check in with a member of the research team, questionnaires, and optional magnetic resonance imaging (MRI) and electroencephalographic (EEG) recordings at the beginning and end of the 6-week intervention. The investigators think that that the less burdensome personalized program will be just as effective at improving symptoms of anxiety and depression as the general program.

Official Title

Efficacy of Personalized Mobile Cognitive Behavioral Therapy Targeting Anxiety and Depression

Quick Facts

Study Start:2024-08-02
Study Completion:2025-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05699525

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age between 18 and 25 years.
  2. * Primary diagnosis of an anxiety, depressive, or bipolar disorder as determined by a score of 4 or greater on the Clinical Severity Rating of the Anxiety Disorders Interview Schedule (ADIS).
  3. * If an individual is diagnosed with bipolar disorder, they must be currently euthymic or experiencing a depressive episode.
  4. * Access to an Apple iPhone
  1. * History of neurologic disorder that may affect the neural systems of interest or participant's ability to participate
  2. * Lifetime diagnosis of a psychotic disorder.
  3. * Current hypomanic or manic episode.
  4. * Currently in cognitive behavior therapy.
  5. * Change in dose of a psychiatric medication in the past 12 weeks.
  6. * Initiation of psychotherapy in the past 12 weeks.
  7. * Intent or plan to attempt suicide.

Contacts and Locations

Study Contact

Maddy Schier
CONTACT
(646) 289-5271
mas4019@med.cornell.edu
Zareen Mir
CONTACT
(646)-289-5271
zam4005@med.cornell.edu

Principal Investigator

Jennifer Bress, Ph.D.
PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University

Study Locations (Sites)

Weill Cornell Medical College
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Weill Medical College of Cornell University

  • Jennifer Bress, Ph.D., PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-02
Study Completion Date2025-01

Study Record Updates

Study Start Date2024-08-02
Study Completion Date2025-01

Terms related to this study

Additional Relevant MeSH Terms

  • Anxiety Disorders and Symptoms
  • Depression
  • Bipolar Disorder
  • Symptoms